APA (7th ed.) Citation

Schem, C., & Schott, S. (2017). Pharmacologically inactive bisphosphonates as an alternative strategy for targeting osteoclasts: In vivo assessment of 5-fluorodeoxyuridine-alendronate in a preclinical model of breast cancer bone metastases. Journal of bone and mineral research, 32(3), . https://doi.org/10.1002/jbmr.3012

Chicago Style (17th ed.) Citation

Schem, Christian, and Sarah Schott. "Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-fluorodeoxyuridine-alendronate in a Preclinical Model of Breast Cancer Bone Metastases." Journal of Bone and Mineral Research 32, no. 3 (2017). https://doi.org/10.1002/jbmr.3012.

MLA (9th ed.) Citation

Schem, Christian, and Sarah Schott. "Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-fluorodeoxyuridine-alendronate in a Preclinical Model of Breast Cancer Bone Metastases." Journal of Bone and Mineral Research, vol. 32, no. 3, 2017, https://doi.org/10.1002/jbmr.3012.